Clinical Distribution Characteristics and Identification for Significant Liver Inflammation of Patients in Chronic Hepatitis B with Indeterminate Phase

Table 3

Logistic regression analysis of clinical indexes associated with significant liver inflammation in the indeterminate phase.

Variables	Univariate analysis		Multivariate analysis
	OR (95% CI)	value	OR (95% CI)	value
Age (year)	1.012 (0.993–1.032)	<0.001
Sex (male%)	0.784 (0.477–1.289)	0.338
WBC (×10^9/L)	0.990 (0.878–1.115)	0.863
PT	1.756 (1.383–2.230)	<0.001	1.559 (1.210–2.009)	0.001
INR	0.918 (0.699–1.205)	0.537
PLT (×10^9/L)	0.994 (0.990–0.998)	0.001	0.996 (0.992–1.000)	0.045
ALB (U/L)	0.948 (0.910–0.987)	0.010	1.052 (0.918–1.192)	0.141
GLB (U/L)	1.036 (0.997–1.077)	0.069
ALT (U/L)	1.008 (1.003–1.014)	0.003	1.010 (1.002–1.018)	0.014
AST (U/L)	1.011 (1.002–1.019)	0.014	0.991 (0.980–1.002)	0.111
GGT (U/L)	1.011 (1.003–1.018)	0.005
ALP (U/L)	1.010 (1.002–1.017)	0.010	1.006 (0.998–1.014)	0.136
TBIL (U/L)	1.008 (0.990–1.027)	0.383
Log10 (HBV-DNA IU/ml)	1.332 (1.123–1.579)	0.001	1.262 (1.045–1.523)	0.016
Log10 (HBsAg IU/ml)	1.002 (0.769–1.305)	0.991
Anti-HBC (S/CO)	1.047 (0.970–1.131)	0.235